HopeStage
Back to all studies
CompletedNCT00720122

Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Eating disorders

Medication studyAges 12–26United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 12 years to 26 years.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2008
Recruitment status
Completed
Enrollment listed in the registry
28
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 12 Years to 26 Years
Official registry ID
NCT00720122
Official title
Show the full official title

Effects of Recombinant Human Insulin Like Growth Factor-1 (rhIGF-1) on Bone Metabolism in Adolescent Girls With Anorexia Nervosa

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Recombinant human insulin like growth factor-1 (rhIGF-1).

Who was this study for?

Listed age limits: 12 years to 26 years.

Want to explore more studies?

Explore studies